SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 34 filers reported holding SATSUMA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,740,000 | – | 290,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,431,705 | $14,371,000 | 5.72% |
| Ghost Tree Capital, LLC | 904,225 | $5,136,000 | 1.21% |
| RA Capital Management | 5,914,252 | $34,953,000 | 0.53% |
| NEA Management Company, LLC | 2,997,682 | $17,716,000 | 0.40% |
| Vivo Capital, LLC | 1,232,394 | $7,283,000 | 0.26% |
| Monashee Investment Management LLC | 176,057 | $1,040,000 | 0.16% |
| Ikarian Capital, LLC | 676,294 | $3,997,000 | 0.14% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $11,146,000 | 0.13% |
| SAMLYN CAPITAL, LLC | 1,232,394 | $7,283,000 | 0.10% |
| Maven Securities LTD | 173,029 | $1,026,000 | 0.05% |